https://www.thebodypro.com/category/pep-hiv-post-exposure-prophylaxis/tag/news

The Latest

chlamydia

DoxyPEP for STIs: Are We Ready for Prophylactic Doxycycline for MSM on HIV PrEP?

A recent expert debate explored the pros and cons of prescribing the antibiotic as a preventive measure for a subset of people at especially high risk for sexually transmitted infections.

By Michael Broder
busy hospital

To Increase Access to HIV Post-Exposure Prophylaxis, New York State Updated Its Guidelines for Clinicians

If you’re a provider in or outside the state, you’ll want to read these new guidelines.

By Terri Wilder, M.S.W.
Contraception pills on blue background

This Week in HIV Research: Cracking the Contraception Conundrum

July 11, 2019: Seroconversion while on long-acting contraceptives; cardiovascular risk in people with HIV; suboptimal testing in high-prevalence U.S. areas; E/C/F/TAF may be suitable for PEP.

By Barbara Jungwirth and Myles Helfand
Fleur De Kine

New Campaign, Toolkit Gets Providers PrEP'd for Women

New York City aims to expand PrEP and PEP access by educating more clinicians that serve women.

By Kenyon Farrow
Allison Glaser, M.D.

New York City's Hotline for HIV Exposure a Success, Study Finds

A dial-in hotline program in New York City has helped qualified patients access post-exposure prophylaxis (PEP) at their local pharmacies, raising the possibility that remote screening methods could be an important way to bolster PEP use.

By Sony Salzman
Study Finds High Burden of Psychosocial Issues Among PEP Users Img

Study Finds High Burden of Psychosocial Issues Among PEP Users

Researchers examining issues facing post-exposure prophylaxis (PEP) users found that 74% of study participants had at least one psychosocial issue, including depression and/or problematic drug or alcohol use.

By Sean R. Hosein for Canadian AIDS Treatment Information Exchange
U.K. Updates PEP Guidelines: Raltegravir Replaces PIs and No Indication if Positive Partner Has an Undetectable Viral Load Img

U.K. Updates PEP Guidelines: Raltegravir Replaces PIs and No Indication if Positive Partner Has an Undetectable Viral Load

The United Kingdom Chief Medical Officers' Expert Advisory Group on AIDS (EAGA) has issued new guidance for post exposure prophylaxis (PEP) that includes using raltegravir (Isentress) rather than a boosted protease inhibitor.

By Simon Collins for HIV i-Base
At Last, PEP Modernization: A Top HIV Clinical Development of 2013 Img

At Last, PEP Modernization: A Top HIV Clinical Development of 2013

The estimable Paul Sax, M.D., from Brigham and Women's Hospital (a leading force in the break-the-routine CD4+ monitoring movement) called them, "The world's most outdated guidelines." Many health care providers demonstrated their disdain by ignoring...

By David Alain Wohl, M.D.
Promo Image

BASHH/BHIVA PEPSE Guidelines for Comment

Draft UK national guideline on HIV PEPSE 2011 are available for consultation until 5th June 2011.

UK Guideline for the Use of Post-Exposure Prophylaxis for HIV Following Sexual Exposure

The main objective is to ensure the appropriate use of post-ex...

By HIV i-Base
Promo Image

Use of Antiretrovirals for Prevention: PrEP, PEP and ART

Transcript (.pdf)

For more information on this session, including access to speaker presentations, please see the conference Programme-at-a-Glance.

Despite years of prevention efforts, HIV incidence has been inadequately controlled and the HIV/AIDS...

By Henry J. Kaiser Family Foundation